CapsoVision, Inc. (CV)

CIK 0001378325 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-05-14) · 99.1
Latest FY-2025 8-K (2026-03-26) · 99.1  |  8-K (2026-03-20) · 99.1
Q3-2025 8-K (2025-11-13) · 99.1
Q2-2025 8-K (2025-08-14) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Condensed Balance Sheets (unaudited)
Condensed Balance Sheets (unaudited) (P)
Condensed Statements of Operations and Comprehensive Loss (unaudited)
Condensed Statements of Cash Flows (unaudited)
Condensed Statements of Convertible Preferred Stock and Stockholders' Deficit (unaudited)
—
Condensed Statements of Convertible Preferred Stock and Stockholders' Equity (deficit) (unaudited)
Notes
Balance Sheet Components
Capital Stock
—
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Description of Business and Organizational Structure
Fair Value Measurements
Going Concern
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Leases
Net Loss Per Share
Note Payable
Preferred Stock
Related Parties
Revenue and Deferred Revenue
Segments
Stock-based Compensation
Subsequent Events
Summary of Significant Accounting Policies